This blend of effectiveness, safety, and tolerability highlights the potential of omega-3 PUFAs in offering a more comprehensive and patient-centric approach to migraine management, thus enhancing the quality of life for those affected by this incapacitating ailment
doi: 10.1016/j.jfutfo.2023.03.001 28 ChenJThompsonLU
In other words, DONT PUSH IT
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Explore WEIGHT + GUT GLP-1, gut, and metabolic support For clients on weight-loss medications, managing gut-barrier concerns, or building a deeper functional medicine protocol around metabolism and inflammation
If you use oral hormonal contraceptives, discuss this with your prescriber, as data from the tirzepatide SmPC suggest that additional contraceptive precautions may be advisable during initiation and dose escalation of GLP-1/GIP-based therapies, pending specific retatrutide data